Found 12 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

18 years - 75 years
All genders
Phase 2
Interventional
This study investigates the effects of an investigational medication on people with moderate to severe ulcerative colitis (UC). Ulcerative colitis is a condition where the lining of the large intestine becomes inflamed and develops sores. The study will compare different doses of the investigational medication to a placebo, which is …
18 years - 55 years
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication compared to an existing treatment in people with relapsing forms of multiple sclerosis, a condition where the immune system mistakenly attacks the protective covering of the nerves, causing communication problems between the brain and the rest of the body. The study …
12 years or above
All genders
Phase 3
Interventional
This study investigates the effects of an investigational treatment for people with moderate to severe atopic dermatitis (AD). Atopic dermatitis is a skin condition that causes red, itchy, and inflamed skin. The study compares the investigational treatment to a placebo, which is an inactive substance that looks the same but …
18 years or above
All genders
Phase 4
Interventional
This study investigates the effect of an investigational medication compared to standard care in preventing or slowing the decline of lung function in adults with uncontrolled moderate to severe asthma. Asthma is a condition where the airways in the lungs become inflamed and narrow, making it hard to breathe. The …
18 years or above
All genders
Phase 2
Interventional
This study investigates a treatment for people with moderately to severely active Ulcerative Colitis (UC) who have an eosinophilic phenotype. Ulcerative Colitis is a condition where the colon and rectum become inflamed. The study aims to evaluate the safety and effectiveness of an investigational medication compared to a placebo. A …
12 years or above
All genders
Phase 2
Interventional
This study investigates the long-term safety and how well an investigational medication works in people with moderate to severe atopic dermatitis (AD). Atopic dermatitis is a skin condition that causes itchy and inflamed skin. The study is for participants who are 12 years or older.Participants will receive the investigational medication …
40 years - 85 years
All genders
Phase 3
Interventional
This study investigates the safety and tolerability of an investigational medication in patients with Chronic Obstructive Pulmonary Disease (COPD). COPD is a lung condition that makes it hard to breathe. The study involves patients who have already participated in previous clinical trials. The purpose is to gather more information about …
2 years - 5 years
All genders
Phase 3
Interventional
This study investigates the safety and effectiveness of an investigational medication in children aged 2 to under 6 years who have uncontrolled asthma or experience frequent severe wheezing. Uncontrolled asthma means that the usual treatments are not enough to manage the symptoms. The study is divided into two parts. Part …
12 years or above
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication for people with moderate-to-severe atopic dermatitis (AD). Atopic dermatitis is a skin condition that causes itchy, inflamed skin. The study focuses on participants aged 12 years and older who have not responded well to previous treatments, including biologic medications or oral …
18 years or above
All genders
Phase 3
Interventional
This study investigates the long-term safety and tolerability of an investigational medication in adults with different types of multiple sclerosis (MS), such as relapsing MS (RMS), primary progressive MS (PPMS), and non-relapsing secondary progressive MS (NRSPMS). Multiple sclerosis is a condition where the immune system mistakenly attacks the protective covering …
1 - 10 of 12